Stock Price Quote

SHASUN PHARMACEUTICALS LTD.- (AMALGAMATION)

NSE : NABSE : 524552ISIN CODE : INE317A01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE428.850 (0 %)
PREV CLOSE ( ) 428.85
OPEN PRICE ( ) 410.00
BID PRICE (QTY) 428.85 (3881)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 79828
TODAY'S LOW / HIGH ( )407.80 432.05
52 WK LOW / HIGH ( ) 407.8432.05
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1976
Management Info
R Kannan - Chairman S Abhaya Kumar - Managing Director
Registered Office

Address Batra Centre,28, Sardar Patel Road,Guindy,
Chennai,
Tamil Nadu-600032

Phone 91-44-43446700

Email shasun@shasun.com

Website www.shasun.com

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
Listing : BSE, NSE, Chennai, MCX

NEWS

12Nov Avenue Supermarts, ONGC and Bank of In
Avenue Supermarts has purchased retail space in Bengaluru valued at over..
09Jul Sun Pharmaceuticals Industries informs
Sun Pharmaceuticals Industries has informed about press release titled '..
07Dec Buy- Sun Pharma
Hemant Thukral of Aditya Birla Money on CNBC TV18 recommended buying Sun..
07Dec Buy -Sun Pharma
CLSA on NDTV Profit recommended buying Sun Pharmaceuticalswith a target..
18Nov Shasun Pharmaceuticals informs about b
With reference to the earlier letter dated November 17, 2015 regarding t..

Financials

in Millions
QTR Sep 15 ANNUAL 15
Net Profit117.3413.4
Gross Profit 131.1 458.2
Operating Profit 349.51268.2
Net Sales 2684.310784

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  26946.00 (0.74%)
M.Cap ( in Cr)57258.37
Sanofi India (BSE)
peergroup  8118.25 (2.06%)
M.Cap ( in Cr)18696.83
Dr. Reddy's Lab (BSE)
peergroup  6155.15 (1.78%)
M.Cap ( in Cr)102679.14
Divi's Lab (BSE)
peergroup  3436.75 (2.14%)
M.Cap ( in Cr)91234.91
Glaxosmithkline Phar (BSE)
peergroup  1943.10 (3.26%)
M.Cap ( in Cr)32917.29

Shareholding Pattern

FII 5.47%
NON-INSTITUTION 44.27%
MUTUAL FUNDS/UTI 4.62%
PROMOTERS 35.32%
FI/BANKS/INSURANCE 0.54%
GOVERNMENT 0%

About Shasun Pharmaceuticals Ltd.- (Amalgamation)

Shasun Pharmaceuticals Ltd.- (Amalgamation) was incorporated in the year 1976. Its today's share price is 428.85. Its current market capitalisation stands at Rs 2884.25 Cr. In the latest quarter, company has reported Gross Sales of Rs. 11134.25 Cr and Total Income of Rs.10923.09 Cr. The company's management includes Taru Rajesh Mardia, Taru Mayur, S Murali Krishna, Arun Chandra Karmakar, S Vimal Kumar, S Devendra, S Abhaya Kumar, Sunny Sharma, N Subramanian, R Sundara Rajan, R Kannan.

It is listed on the BSE with a BSE Code of 524552 , NSE with an NSE Symbol of SHASUNPHAR and ISIN of INE317A01028. It's Registered office is at Batra Centre,28, Sardar Patel Road,GuindyChennai-600032, Tamil Nadu. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co, BSR & Co LLP, Jagadisan & Co, Jagdisan & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.